Lake Street Maintains Buy on Biodesix, Lowers Price Target to $30

Benzinga · 2d ago
Lake Street analyst Thomas Flaten maintains Biodesix (NASDAQ:BDSX) with a Buy and lowers the price target from $40 to $30.